Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Increased in vitro differentiation of fibrocytes from keloid patients is inhibited by serum amyloid P.

Naylor MC, Lazar DA, Zamora IJ, Mushin OP, Yu L, Brissett AE, Olutoye OO.

Wound Repair Regen. 2012 May-Jun;20(3):277-83. doi: 10.1111/j.1524-475X.2012.00782.x.

PMID:
22564223
2.

First identification of resident and circulating fibrocytes in Dupuytren's disease shown to be inhibited by serum amyloid P and Xiapex.

Iqbal SA, Hayton MJ, Watson JS, Szczypa P, Bayat A.

PLoS One. 2014 Jun 16;9(6):e99967. doi: 10.1371/journal.pone.0099967. eCollection 2014.

3.

Identification of fibrocytes from mesenchymal stem cells in keloid tissue: a potential source of abnormal fibroblasts in keloid scarring.

Iqbal SA, Sidgwick GP, Bayat A.

Arch Dermatol Res. 2012 Oct;304(8):665-71. doi: 10.1007/s00403-012-1225-5. Epub 2012 Mar 11.

PMID:
22407077
4.

Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.

Dienus K, Bayat A, Gilmore BF, Seifert O.

Arch Dermatol Res. 2010 Dec;302(10):725-31. doi: 10.1007/s00403-010-1084-x. Epub 2010 Sep 26.

PMID:
20872224
5.

Inhibition of fibrocyte differentiation by serum amyloid P.

Pilling D, Buckley CD, Salmon M, Gomer RH.

J Immunol. 2003 Nov 15;171(10):5537-46.

6.
7.

Improved serum-free culture conditions for spleen-derived murine fibrocytes.

Crawford JR, Pilling D, Gomer RH.

J Immunol Methods. 2010 Dec 15;363(1):9-20. doi: 10.1016/j.jim.2010.09.025. Epub 2010 Oct 1.

8.

Keloid-derived fibroblasts have a diminished capacity to produce prostaglandin E2.

Yeh FL, Shen HD, Lin MW, Chang CY, Tai HY, Huang MH.

Burns. 2006 May;32(3):299-304. Epub 2006 Feb 17.

PMID:
16487663
9.

Circulating fibrocytes--biology and mechanisms in wound healing and scar formation.

Grieb G, Steffens G, Pallua N, Bernhagen J, Bucala R.

Int Rev Cell Mol Biol. 2011;291:1-19. doi: 10.1016/B978-0-12-386035-4.00001-X. Review.

PMID:
22017972
10.

Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion.

Ong CT, Khoo YT, Tan EK, Mukhopadhyay A, Do DV, Han HC, Lim IJ, Phan TT.

J Pathol. 2007 Jan;211(1):95-108.

PMID:
17136757
11.
12.

Serum amyloid P inhibits dermal wound healing.

Naik-Mathuria B, Pilling D, Crawford JR, Gay AN, Smith CW, Gomer RH, Olutoye OO.

Wound Repair Regen. 2008 Mar-Apr;16(2):266-73. doi: 10.1111/j.1524-475X.2008.00366.x.

13.

Insulin-like growth factor-I (IGF-I)/IGF-I receptor axis and increased invasion activity of fibroblasts in keloid.

Ohtsuru A, Yoshimoto H, Ishihara H, Namba H, Yamashita S.

Endocr J. 2000 Mar;47 Suppl:S41-4.

14.
15.

A brief exposure to tryptase or thrombin potentiates fibrocyte differentiation in the presence of serum or serum amyloid p.

White MJ, Galvis-Carvajal E, Gomer RH.

J Immunol. 2015 Jan 1;194(1):142-50. doi: 10.4049/jimmunol.1401777. Epub 2014 Nov 26.

16.

Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts in vitro.

Chipev CC, Simman R, Hatch G, Katz AE, Siegel DM, Simon M.

Cell Death Differ. 2000 Feb;7(2):166-76.

17.

Vitamin D: a novel therapeutic approach for keloid, an in vitro analysis.

Zhang GY, Cheng T, Luan Q, Liao T, Nie CL, Zheng X, Xie XG, Gao WY.

Br J Dermatol. 2011 Apr;164(4):729-37. doi: 10.1111/j.1365-2133.2010.10130.x. Epub 2011 Mar 16.

PMID:
21070203
18.

Differentiation of circulating monocytes into fibroblast-like cells.

Pilling D, Gomer RH.

Methods Mol Biol. 2012;904:191-206. doi: 10.1007/978-1-61779-943-3_16.

19.

Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis.

Dillingh MR, van den Blink B, Moerland M, van Dongen MG, Levi M, Kleinjan A, Wijsenbeek MS, Lupher ML Jr, Harper DM, Getsy JA, Hoogsteden HC, Burggraaf J.

Pulm Pharmacol Ther. 2013 Dec;26(6):672-6. doi: 10.1016/j.pupt.2013.01.008. Epub 2013 Feb 4.

PMID:
23380438
20.

Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth.

Russell SB, Trupin KM, Rodríguez-Eaton S, Russell JD, Trupin JS.

Proc Natl Acad Sci U S A. 1988 Jan;85(2):587-91.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk